Purchases and Sales Made in Q2 2022 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q2 2022. The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 03, 2022
Q2 2022
|
Candriam S.C.A.
|
SELL
|
- |
-58.9K- 14.0% |
$1.53M - $3.95M
|
362K
$4.13M
|
|
|
Aug 12, 2022
Q2 2022
|
First Light Asset Management, LLC
Edina, MN |
SELL
|
- |
-59.8K- 9.09% |
$1.56M - $4.01M
|
598K
$6.83M
|
|
|
Aug 15, 2022
Q2 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-65.7KClosed |
$1.71M - $4.4M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-71.6K- 51.28% |
$1.86M - $4.8M
|
68K
$776K
|
|
|
Aug 03, 2022
Q2 2022
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-81KClosed |
$2.11M - $5.43M
|
0
$0
|
|
|
Aug 01, 2022
Q2 2022
|
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD
|
SELL
|
- |
-95.6KClosed |
$2.49M - $6.41M
|
0
$0
|
|
|
Aug 01, 2022
Q2 2022
|
Meitav Dash Investments LTD
|
SELL
|
- |
-95.6K- 84.55% |
$2.49M - $6.41M
|
17.5K
$199K
|
|
|
Aug 15, 2022
Q2 2022
|
Fairmount Funds Management LLC
Philadelphia, PA |
SELL
|
- |
-124K- 31.35% |
$3.24M - $8.34M
|
272K
$3.11M
|
|
|
Aug 15, 2022
Q2 2022
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-188K- 55.25% |
$4.89M - $12.6M
|
152K
$1.74M
|
|
|
Aug 15, 2022
Q2 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-257KClosed |
$6.69M - $17.2M
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-641K- 46.42% |
$16.7M - $43M
|
740K
$8.44M
|